The latest update is out from SoftOx Solutions AS ( (DE:6FV) ).
SoftOx Solutions AS has resolved a legal dispute with a former consultant over a bonus claim related to services rendered in 2022. The settlement involves an immediate payment of MNOK 1.5 and a deferred payment of MNOK 0.8 by June 2026, potentially impacting the company’s financial obligations and stakeholder relations.
More about SoftOx Solutions AS
SoftOx Solutions AS is a pharmaceutical company listed on Euronext Growth Oslo, specializing in developing antimicrobial solutions for biofilm, viral, and antimicrobial-resistant infections. Founded in 2012 and headquartered in Oslo, the company collaborates with leading Nordic research institutes to advance its patent-protected technology.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €5.58M
Learn more about 6FV stock on TipRanks’ Stock Analysis page.